Monitoring public attention · Explaining only what evidence can support
WHY IS THIS TRENDING

Entity dossier

fda mrna flu vaccine

1 recorded attention episode across US.

At a glance

The dossier

Episodes
1
Verified stories
1
Regions
US
Coverage signals
6

Tracked from through .

Interactive attention record

Latest episode

WITT Attention Index for fda mrna flu vaccine in US. It combines a public traffic bucket, change in that bucket, attached coverage and cross-region presence.
View accessible data table
ObservedTraffic bucketAttention Index
1000+ 56.0
1000+ 55.0
1000+ 55.0
1000+ 55.0

Episode history

Verified explanations

ended Science

Moderna’s mRNA Flu Shot Wins FDA Approval After Dramatic Reversal

The U.S. Food and Drug Administration approved Moderna's mFlusiva mRNA flu vaccine for adults 50 and older on August 5, 2026, just weeks after an initial refusal to review the application. The approval clears the way for commercial availability this fall, though patients face potential hurdles with insurance coverage due to stalled federal advisory panels.

Index 0 US WITT Editorial Desk